ABUS vs MDB · P/E 5.4, rev $6.2M vs rev $2.46B
Arbutus Biopharma Corp (ABUS) versus MongoDB (MDB) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
MongoDB (MDB) is a software - infrastructure company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MDB revenue for 2026-01-31 was $2.46B. Net income was -$71.2M. Revenue was up 22.8% from 2025-01-31 to 2026-01-31. MDB currently screens at market cap $17.16B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MDB currently screens at market cap $17.16B.
Not investment advice. Open the ABUS and MDB stock pages for the full models.
Not investment advice.